EU agency recommends against Zentiva's Coxtral gel
LONDON, June 2 (Reuters) - The European Medicines Agency has reiterated its decision against recommending approval of Zentiva's ZNTVsp.PR Coxtral gel for relief of pain associated with sprains and acute traumatic tendinitis.
The London-based watchdog said on Monday that the decision confirms its February opinion recommending against refusal to grant marketing approval for the drug in Europe. (Reporting by Michael Kahn)
© Thomson Reuters 2009 All rights reserved
Pledge to support economies
G20 financial leaders pledged to prepare strategies to end emergency support for their economies, but to keep the aid flowing until recovery was assured. Full Article | Related Story
Galleon case
U.S. insider trading probe widens
Fourteen people were charged with fraud and conspiracy in a dramatic widening of an insider trading scandal. Full Article
India
US
UK
